Key facts
- Briotech’s last known valuation is $25.0M.
- It has raised $20.6M across 3 recorded rounds; the latest was Seed Round ($2.0M) in Dec 2024.
- Notable investors include Decathlon Capital Partners, Fledge (Seattle), Humanitas Capital Management, Level Eight Ventures, The Assay Group.
- Briotech has filed 9 Form Ds with the SEC since 2016, most recently Apr 2025 ($6.0M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Briotech
Funding rounds
3 roundsAbout Briotech
Manufacturer of hypochlorous acid-based products intended to improve the delivery of healthcare and infection control measures. The company's products include topical skin spray, multi-surface sanitizer, and electrolyzed hand spray that are infused with germ-killing properties, enabling healthcare professionals to fight against infection, reduce inflammation, control responses to injury, and enhance the healing process.
- Sector
- Materials and Resources
- HQ
- Everett, WA, United States
- Founded
- 2013
- Employees
- 45
- Website
- shopbriotech.com/
- Ownership
- Privately Held (backing)
Briotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Briotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Briotech in its N-PORT filings yet. We sweep new filings monthly.